Anqi Wu
Current Organizations / Institutes
The organizations/institutes from the scholar's latest article
Research Subjects
Anqi Wu has a total of 47 co-authors. Here are the top co-authors by number of shared publications:
Wanbing Guan
4 shared publicationsBeibei Han
2 shared publicationsFei Wang
2 shared publicationsYunfang Gao
2 shared publications- Aiting Cai
School of Public Health, Nantong University, No.9 Seyuan Road, Nantong 226019, China
1 shared publication Bei-Bei Han
Key Laboratory of Advanced Fuel Cells and Electrolyzers Technology of Zhejiang Province, Ningbo Institute of Materials Technology and Engineering, Chinese Academy of Sciences, Ningbo 315201, Zhejiang, PR China
1 shared publication
Latest Publications
- 15 April 2026
- Published by Elsevier in Biochemical Pharmacology
- Vol. 250 (Pt 1) , 117988
Oncogenic tRF-24-O7M8LO9LIM drives lung adenocarcinoma progression by disrupting the CD82/p53 tumor suppressor pathway
- 15 April 2026
- Published by Elsevier in Biochemical Pharmacology
- Vol. 250 (Pt 1) , 117988
Oncogenic tRF-24-O7M8LO9LIM drives lung adenocarcinoma progression by disrupting the CD82/p53 tumor suppressor pathway
- Open Access
- 28 April 2025
- Published by (Xiamen: Dianhuaxue Bianjibu) Editorial Office of Journal of Electrochemistry, Xiamen University in Journal of Electrochemistry
- Vol. 31 (4) , 3
Performance of CO2/H2O Co-electrolysis in a Flat-tube Solid Oxide Electrolysis Cell Stack under Air-free Environment
This work investigates the transient performance and stability of CO2/H2O co-electrolysis in an air-free environment using a flat-tube solid oxide electrolysis cell (SOEC) stack. The results show that the transient behavior of the stack with and without blowing gas in the air electrode is almost the same. With a current density of 0.67 A·cm−2@750 °C, the stack operated for over 200 h under co-electrolysis conditions with no air blowing, and the voltage drop rate of the stack was approximately 0.203%/100 hours. Microstructure analysis reveals significant loss of Ni particles and formation of an insulating phase SrCrO4 on the surface of the current collection layer of the air electrode, which are identified as key factors contributing to performance degradation of the stack. This study provides a reference for efficient fuel preparation technology based on SOEC stack in airless environments.
- 28 April 2025
- Published by (Xiamen: Dianhuaxue Bianjibu) Editorial Office of Journal of Electrochemistry, Xiamen University in Journal of Electrochemistry
- Vol. 31 (4) , 3
Open AccessPerformance of CO2/H2O Co-electrolysis in a Flat-tube Solid Oxide Electrolysis Cell Stack under Air-free Environment
This work investigates the transient performance and stability of CO2/H2O co-electrolysis in an air-free environment using a flat-tube solid oxide electrolysis cell (SOEC) stack. The results show that the transient behavior of the stack with and without blowing gas in the air electrode is almost the same. With a current density of 0.67 A·cm−2@750 °C, the stack operated for over 200 h under co-electrolysis conditions with no air blowing, and the voltage drop rate of the stack was approximately 0.203%/100 hours. Microstructure analysis reveals significant loss of Ni particles and formation of an insulating phase SrCrO4 on the surface of the current collection layer of the air electrode, which are identified as key factors contributing to performance degradation of the stack. This study provides a reference for efficient fuel preparation technology based on SOEC stack in airless environments.
- 9 April 2025
- Published by Elsevier in Journal of Alloys and Compounds
- Vol. 1024
The application of cobalt-free spinel Ni1.4Mn1.6O4 as a cathode in intermediate temperature solid oxide fuel cells
- 9 April 2025
- Published by Elsevier in Journal of Alloys and Compounds
- Vol. 1024
The application of cobalt-free spinel Ni1.4Mn1.6O4 as a cathode in intermediate temperature solid oxide fuel cells
- 29 May 2023
- Published by Royal Society of Chemistry (RSC) in Sustainable Energy & Fuels
- Vol. 7 (14) , 3333-3341
Effect of the steam/hydrogen ratio on the performance of flat-tube solid oxide electrolysis cells for seawater
This work investigated the durability of seawater electrolysis and degradation mechanism for hydrogen production at different seawater steam contents using a flat-tube solid oxide electrolysis cell (SOEC). The results showed that the cells ran stably for 1000 hours at 62 and 67% seawater steam contents with degradation rates of 48 mV kh−1 and 129 mV kh−1, respectively. The degradation at different seawater steam contents is mainly concentrated in the fuel electrode of the cell and is ascribed to the migration, agglomeration, and loss of Ni particles. This study effectively brings out the issues seen in the long-term application of solid oxide electrolysis cells in seawater environments.
- 29 May 2023
- Published by Royal Society of Chemistry (RSC) in Sustainable Energy & Fuels
- Vol. 7 (14) , 3333-3341
Effect of the steam/hydrogen ratio on the performance of flat-tube solid oxide electrolysis cells for seawater
This work investigated the durability of seawater electrolysis and degradation mechanism for hydrogen production at different seawater steam contents using a flat-tube solid oxide electrolysis cell (SOEC). The results showed that the cells ran stably for 1000 hours at 62 and 67% seawater steam contents with degradation rates of 48 mV kh−1 and 129 mV kh−1, respectively. The degradation at different seawater steam contents is mainly concentrated in the fuel electrode of the cell and is ascribed to the migration, agglomeration, and loss of Ni particles. This study effectively brings out the issues seen in the long-term application of solid oxide electrolysis cells in seawater environments.
- Open Access
- 7 September 2022
- Published by Springer Nature in Journal of Experimental & Clinical Cancer Research
- Vol. 41 (1) , 1-17
Hsa_circ_0000098 is a novel therapeutic target that promotes hepatocellular carcinoma development and resistance to doxorubicin
Background: Circular RNA (circRNA) is crucial to the progression of hepatocellular cancer (HCC). In addition, Mitochondrial calcium uniporter regulatory factor 1 (MCUR1) is commonly overexpressed in HCC to increase cellular ATP levels. Due to the highly aggressive characteristics of HCC, it is essential to identify new diagnostic biomarkers and therapeutic targets that may facilitate the diagnosis of HCC and the development of effective anti-HCC treatments. Methods: A series of in vitro and in vivo experiments were undertaken to investigate the biological importance and underlying mechanisms of circ_0000098 in HCC. Results: The expression of circ_0000098 was higher in HCC tissues compared to paired adjacent tissues. According to the receiver-operating characteristic curves, circ_0000098 functioned as a potential diagnostic tumor marker in HCC. Our experiments indicated that circ_0000098 served as a key oncogenic circRNA to increase HCC cell proliferation and invasion in vitro and HCC progression in vivo. Furthermore, mechanistic investigation demonstrated that by sequestering miR-383 from the 3′-UTR of MCUR1, circ_0000098 positively regulated MCUR1 expression in HCC cells and finally promoted HCC progression. On the other hand, inhibiting circ_0000098 in HCC cells could diminish doxorubicin (DOX) resistance by decreasing P-glycoprotein (P-gp, MDR1) expression and intracellular ATP levels. Either downregulation of MCUR1 or overexpression of miR-383 improved DOX sensitivity in HCC cells. Subsequently, a short hairpin RNA targeting circ_0000098 (referred to as sh-1) and doxorubicin (DOX) were encapsulated into platelets (PLTs), referred to as DOX/sh-1@PLT. Activated DOX/sh-1@PLT through HCC cells resulted in the creation of platelet-derived particles that were capable of delivering the DOX/sh-1 combination into HCC cells and promoting intracellular DOX accumulation. Furthermore, our in vivo experiments showed that DOX/sh-1@PLT can effectively reduce P-gp expression, promote DOX accumulation, and reverse DOX resistance. Conclusions: Our results demonstrated that circ_0000098 is an oncogenic circRNA that promotes HCC development through the miR-383/MCUR1 axis and targeting circ_0000098 with DOX/sh-1@PLT may be a promising and practical therapeutic strategy for preventing DOX resistance in HCC.
- 7 September 2022
- Published by Springer Nature in Journal of Experimental & Clinical Cancer Research
- Vol. 41 (1) , 1-17
Open AccessHsa_circ_0000098 is a novel therapeutic target that promotes hepatocellular carcinoma development and resistance to doxorubicin
Background: Circular RNA (circRNA) is crucial to the progression of hepatocellular cancer (HCC). In addition, Mitochondrial calcium uniporter regulatory factor 1 (MCUR1) is commonly overexpressed in HCC to increase cellular ATP levels. Due to the highly aggressive characteristics of HCC, it is essential to identify new diagnostic biomarkers and therapeutic targets that may facilitate the diagnosis of HCC and the development of effective anti-HCC treatments. Methods: A series of in vitro and in vivo experiments were undertaken to investigate the biological importance and underlying mechanisms of circ_0000098 in HCC. Results: The expression of circ_0000098 was higher in HCC tissues compared to paired adjacent tissues. According to the receiver-operating characteristic curves, circ_0000098 functioned as a potential diagnostic tumor marker in HCC. Our experiments indicated that circ_0000098 served as a key oncogenic circRNA to increase HCC cell proliferation and invasion in vitro and HCC progression in vivo. Furthermore, mechanistic investigation demonstrated that by sequestering miR-383 from the 3′-UTR of MCUR1, circ_0000098 positively regulated MCUR1 expression in HCC cells and finally promoted HCC progression. On the other hand, inhibiting circ_0000098 in HCC cells could diminish doxorubicin (DOX) resistance by decreasing P-glycoprotein (P-gp, MDR1) expression and intracellular ATP levels. Either downregulation of MCUR1 or overexpression of miR-383 improved DOX sensitivity in HCC cells. Subsequently, a short hairpin RNA targeting circ_0000098 (referred to as sh-1) and doxorubicin (DOX) were encapsulated into platelets (PLTs), referred to as DOX/sh-1@PLT. Activated DOX/sh-1@PLT through HCC cells resulted in the creation of platelet-derived particles that were capable of delivering the DOX/sh-1 combination into HCC cells and promoting intracellular DOX accumulation. Furthermore, our in vivo experiments showed that DOX/sh-1@PLT can effectively reduce P-gp expression, promote DOX accumulation, and reverse DOX resistance. Conclusions: Our results demonstrated that circ_0000098 is an oncogenic circRNA that promotes HCC development through the miR-383/MCUR1 axis and targeting circ_0000098 with DOX/sh-1@PLT may be a promising and practical therapeutic strategy for preventing DOX resistance in HCC.